Gerard Quigley
Payments from drug & device makers
Across 97 payments — averaging $14.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$450
- AbbVie$274
- Teva Pharmaceuticals USA, Inc.$94
- Boston Scientific$73
- Collegium Pharmaceutical, Inc.$68
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$65
- plus $404 from 14 others
What the payments were for
- Food & beverage$1,40398%
- Education$242%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 39 | $450 |
| AbbVie(2 entities) | 17 | $274 |
| Teva Pharmaceuticals USA, Inc. | 5 | $94 |
| Boston Scientific | 4 | $73 |
| Collegium Pharmaceutical, Inc. | 4 | $68 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $65 |
| Biohaven Pharmaceuticals, Inc. | 4 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| Pacira Therapeutics, Inc. | 2 | $41 |
| Biodelivery Sciences International, Inc. | 3 | $38 |
| Almatica Pharma LLC | 3 | $36 |
| Redhill Biopharma Inc. | 2 | $35 |
| Medtronic | 1 | $27 |
| GSK | 1 | $22 |
| Scilex Pharmaceuticals Inc. | 1 | $17 |
| Bardy Diagnostics, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| AstraZeneca | 1 | $14 |
| Dova Pharmaceuticals | 1 | $14 |
| Otto Bock Healthcare LP | 1 | $13 |
How this compares
$1,427 in reported general payments places this provider in the 65th percentile of 748 medical providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 42 | $27,103 |
| Oxycodone Hcl | 1,020 | $19,649 |
| BelbucaBuprenorphine Hcl | 19 | $18,668 |
| OxycontinOxycodone Hcl | 25 | $17,938 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 430 | $13,745 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 319 | $11,999 |
| Morphine Sulfate ErMorphine Sulfate | 295 | $8,156 |
| Fentanyl | 51 | $4,786 |
| Gabapentin | 228 | $3,936 |
| Naloxone Hcl | 42 | $2,451 |
| Pregabalin | 110 | $2,316 |
| Tramadol Hcl | 148 | $2,016 |
| Lidocaine | 24 | $1,932 |
| Hydromorphone Hcl | 56 | $1,892 |
| Cyclobenzaprine Hcl | 88 | $1,851 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $68 | $45,77061 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 748 medical providers in Arizona.
Other medical in Mesa
- Anngela EdkinsMesa$16K
- Tasha MackMesa$14K
- Dana HoffmanMesa$14K
- Laurie PetersonMesa$12K
- Robert CasquejoScottsdale$474K
- Andrew HicksPeoria$460K
- Darren WestScottsdale$206K
- Linda MoorsTucson$122K
- Jamie WystrachScottsdale$79K
- Scott YoungPhoenix$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.